CommercialCoverageMedium impact
State and School Employees' Health Insurance Plan - Hemophilia Therapies
Blue Cross & Blue Shield of Mississippi·MS · Hematology, Pediatrics·Medical Policy
We identified it
Jun 20, 2026
Summary
This is a new medical policy for State and School Employees' Health Insurance Plan covering hemophilia therapies. The policy establishes coverage criteria requiring specific diagnoses, current bleeding, and detailed documentation. Five specific drugs (Esperoct, Hympavzi, Jivi, Qfitlia, and Roctavian) are deemed not medically necessary.
Action Required
Immediately: Update billing system to flag hemophilia therapy claims for prior authorization review. Verify coverage criteria are met before billing including diagnosis confirmation, current bleeding status, and complete documentation (age, weight, severity, activity level, bleed history, trough levels, inhibitor status). Do not bill for Esperoct, Hympavzi, Jivi, Qfitlia, or Roctavian as they are not covered. Route self-administered hemophilia drugs to pharmacy benefit manager instead of medical billing.